Drug
Bgb B2033
Bgb B2033: highest development phase Phase 3, developed by BeOne Medicines. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- BeOne Medicines
Trials
| Drug | Phase | Indication |
|---|---|---|
| BGB-B2033 NCT07836530 | Phase 3 | Hepatocellular Carcinoma |
Latest
No recent events.
Follow Bgb B2033 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.